ArticleBiochemical genetics2026

Acute Myeloid Leukemia Patients with High-Risk Karyotypes Benefit from Decitabine in Combination with Modified CAG.

Ping Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.